Exeltis USA (Pharmaceuticals) Overview

  • Year Founded
  • 1971

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4,000

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 3

Exeltis USA (Pharmaceuticals) General Information

Description

Operator of a pharmaceutical company intended to serve women. The company's mission is to improve the health of women by providing access to innovative, effective therapeutic products by offering estrogen-free oral contraceptives, prenatal vitamins, antimicrobial Nuvessa, in-office detection of vaginitis associated with bacterial vaginosis and dietary supplements that safely and easily help to promote male fertility and reproductive health, enabling its customers to avail the products for an enhanced and healthier living.

Contact Information

Website
www.exeltisusa.com
Formerly Known As
Everett Laboratories
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 180 Park Avenue
  • Suite 101
  • Florham Park, NJ 07932
  • United States
+1 (973)
Primary Industry
Pharmaceuticals
Parent Company
Insud Pharma
Corporate Office
  • 180 Park Avenue
  • Suite 101
  • Florham Park, NJ 07932
  • United States
+1 (973)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exeltis USA (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Exeltis USA (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Exeltis USA (Pharmaceuticals) Patents

  • 122

    Total Documents Applications and Grants

  • Total Patents Families

  • 29

    Granted

  • Pending

  • Expiring in next 12 mo

Exeltis USA (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3011848-A1 Orally dissolvable compositions for nutrition supplementation Inactive 21-Jul-2017
US-20190021385-A1 Orally dissolvable compositions for nutrition supplementation Inactive 21-Jul-2017
US-20170202802-A1 Compositions, kits and methods for nutrition supplementation Inactive 20-Jan-2016
US-20150305386-A1 Compositions for nutritional supplementation Inactive 28-Apr-2014
US-20150258020-A1 Chewable tablets comprising levonorgestrel Inactive 17-Mar-2014 A61K9/0056
To view Exeltis USA (Pharmaceuticals)’s complete patent history, request access »

Exeltis USA (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exeltis USA (Pharmaceuticals) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Exeltis USA (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Exeltis USA (Pharmaceuticals) Investments & Acquisitions (3)

Exeltis USA (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with Agile Therapeutics for . The deal was made on 26-Aug-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Agile Therapeutics 26-Aug-2024 Merger/Acquisition Pharmaceuticals
Choiz 01-Jul-2022 Seed Round Clinics/Outpatient Services
Exeltis USA Dermatology 16-Dec-2013 Merger/Acquisition Pharmaceuticals
To view Exeltis USA (Pharmaceuticals)’s complete investments and acquisitions history, request access »

Exeltis USA (Pharmaceuticals) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Agile Therapeutics Princeton, NJ 1997

Exeltis USA (Pharmaceuticals) FAQs

  • When was Exeltis USA (Pharmaceuticals) founded?

    Exeltis USA (Pharmaceuticals) was founded in 1971.

  • Where is Exeltis USA (Pharmaceuticals) headquartered?

    Exeltis USA (Pharmaceuticals) is headquartered in Florham Park, NJ.

  • What is the size of Exeltis USA (Pharmaceuticals)?

    Exeltis USA (Pharmaceuticals) has 4,000 total employees.

  • What industry is Exeltis USA (Pharmaceuticals) in?

    Exeltis USA (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Exeltis USA (Pharmaceuticals) a private or public company?

    Exeltis USA (Pharmaceuticals) is a Private company.

  • What is the current valuation of Exeltis USA (Pharmaceuticals)?

    The current valuation of Exeltis USA (Pharmaceuticals) is .

  • What is Exeltis USA (Pharmaceuticals)’s current revenue?

    The current revenue for Exeltis USA (Pharmaceuticals) is .

  • Who are Exeltis USA (Pharmaceuticals)’s investors?

    Mangrove Equity Partners has invested in Exeltis USA (Pharmaceuticals).

  • When was Exeltis USA (Pharmaceuticals) acquired?

    Exeltis USA (Pharmaceuticals) was acquired on 16-Mar-2010.

  • Who acquired Exeltis USA (Pharmaceuticals)?

    Exeltis USA (Pharmaceuticals) was acquired by Insud Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process